Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), Journal of the Pediatric Infectious Diseases Society
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health
Dyson ZA. et al, (2025), Genome Medicine, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Dold C. et al, (2025), Science Translational Medicine, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.
Siegal EZ. et al, (2025), NPJ vaccines, 10
Pneumococcal Carriage and Disease in Adults in England, 2011–2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
El Safadi D. et al, (2025), The Journal of Infectious Diseases, 231, e17 - e27
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Viz-Lasheras S. et al, (2025), iScience, 28, 111747 - 111747
A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment
Viz-Lasheras S. et al, (2025), Nature Communications, 16
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.
Khanam F. et al, (2025), BMC infectious diseases, 25
Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial
Conlin K. et al, (2025), Vaccine, 45, 126582 - 126582
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Kristensen M. et al, (2024), Cell reports. Medicine, 5
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Terstappen J. et al, (2024), The Lancet. Infectious diseases, 24, e747 - e761
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Amodio D. et al, (2024), Vaccine, 43
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
Lin L. et al, (2024), PLoS computational biology, 20
New programme to prevent bronchiolitis in infants
Pollard AJ. et al, (2024), Archives of Disease in Childhood
5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial
Qadri F. et al, (2024), The Lancet, 404, 1419 - 1429